US Patent 7960341 Methods and compositions for treating polycystic ovary syndrome
Patent 7960341 was granted and assigned to Amylin Pharmaceuticals on June, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+234 characters)
Article
Patent abstract
The present invention relates to methods of treating polycystic ovary syndrome (PCOS) comprising administering glucagon-like peptide-1 (GLP-1), exendin, and analogs and agonists thereof, to subjects suffering therefrom.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Andrew A. Young0
David R. Hathaway0
Kathryn Susan Prickett0
Nigel Robert Arnold Beeley0
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07960341 Methods and compositions for treating polycystic ovary syndrome US Patent 7960341 Methods and compositions for treating polycystic ovary syndrome
Infobox
Patent Number
079603410
Patent Number
79603410
Edits on 4 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079603410
Date of Patent
June 14, 2011
0Patent Application Number
115185740
Date Filed
September 8, 2006
0Patent Primary Examiner
Edits on 7 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07960341 Methods and compositions for treating polycystic ovary syndrome
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07960341
Date of patent
June 14, 2011
Patent application number
11518574
Date Filed
September 8, 2006
Patent primary examiner
Find more entities like US Patent 7960341 Methods and compositions for treating polycystic ovary syndrome
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
